Annual Total Liabilities
$19.05 M
+$641.00 K+3.48%
31 December 2023
Summary:
NRx Pharmaceuticals annual total liabilities is currently $19.05 million, with the most recent change of +$641.00 thousand (+3.48%) on 31 December 2023. During the last 3 years, it has fallen by -$27.66 million (-59.22%). NRXPW annual total liabilities is now -59.22% below its all-time high of $46.71 million, reached on 31 December 2020.NRXPW Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$23.28 M
-$371.00 K-1.57%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly total liabilities is currently $23.28 million, with the most recent change of -$371.00 thousand (-1.57%) on 30 September 2024. Over the past year, it has increased by +$3.96 million (+20.47%). NRXPW quarterly total liabilities is now -65.10% below its all-time high of $66.71 million, reached on 31 March 2019.NRXPW Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.5% | +20.5% |
| 3 y3 years | -59.2% | -35.8% |
| 5 y5 years | - | -36.5% |
NRXPW Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.2% | +59.8% | -35.8% | +228.8% |
| 5 y | 5 years | -59.2% | +59.8% | -36.5% | >+9999.0% |
| alltime | all time | -59.2% | +59.8% | -65.1% | >+9999.0% |
NRx Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.28 M(-1.6%) |
| June 2024 | - | $23.66 M(+25.4%) |
| Mar 2024 | - | $18.86 M(-1.0%) |
| Dec 2023 | $19.05 M(+3.5%) | $19.05 M(-1.4%) |
| Sept 2023 | - | $19.33 M(+172.9%) |
| Dec 2022 | $18.41 M(+54.4%) | - |
| June 2022 | - | $7.08 M(-40.6%) |
| Mar 2022 | - | $11.91 M(-0.1%) |
| Dec 2021 | $11.92 M | $11.92 M(-67.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $36.28 M(+0.8%) |
| June 2021 | - | $35.98 M(>+9900.0%) |
| Dec 2020 | $46.71 M(+72.5%) | $3281.55(>+9900.0%) |
| Sept 2020 | - | $2.83(-100.0%) |
| June 2020 | - | $2.65 M(+6.2%) |
| Mar 2020 | - | $2.50 M(-90.8%) |
| Dec 2019 | $27.07 M | $27.07 M(-26.2%) |
| Sept 2019 | - | $36.69 M(-18.7%) |
| June 2019 | - | $45.10 M(-32.4%) |
| Mar 2019 | - | $66.71 M |
FAQ
- What is NRx Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual total liabilities year-on-year change?
- What is NRx Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly total liabilities year-on-year change?
What is NRx Pharmaceuticals annual total liabilities?
The current annual total liabilities of NRXPW is $19.05 M
What is the all time high annual total liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total liabilities is $46.71 M
What is NRx Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, NRXPW annual total liabilities has changed by +$641.00 K (+3.48%)
What is NRx Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of NRXPW is $23.28 M
What is the all time high quarterly total liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total liabilities is $66.71 M
What is NRx Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, NRXPW quarterly total liabilities has changed by +$3.96 M (+20.47%)